The current study nevertheless showed that chemerin protein was induced in tumor tissues of European HCC patients with non-alcoholic fatty liver disease (NAFLD) and patients with unclear disease etiology. Here, RARRES2 is linked to metabolic dysfunction-associated steatotic liver disease.